PDAC

You have access
Splicing Factor SF3B4 Suppresses Pancreatic Cancer Growth and Migration by Inhibiting Autophagy
SO-HYUN CHOI, JIYOON SEO and SEUNG MIN JEONG

Anticancer Research February 2026, 46 (2) 737-747; DOI: https://doi.org/10.21873/anticanres.17983
You have access
Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis
RUJIA LI, TING YANG, KE REN, JUN LI, YUICHI NAGAKAWA, YUHAO ZENG, YUTARO NATSUYAMA and SHUANG-QIN YI

Anticancer Research October 2024, 44 (10) 4233-4250; DOI: https://doi.org/10.21873/anticanres.17254
You have access
Synchronous Pancreatic Ductal Adenocarcinoma and Nasopharyngeal Carcinoma With Associated Novel Pathogenic ATM Mutation
LILY XU, AMANDA TIAN, RUOHAO FAN and JINPING LAI

Anticancer Research October 2024, 44 (10) 4605-4608; DOI: https://doi.org/10.21873/anticanres.17290
You have access
Prognostic Significance of ¹⁸F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma
AYAKA SHIMOMURA, MINORU OSHIMA, HIRONOBU SUTO, HIROYUKI MATSUKAWA, AKIHIRO KONDO, YASUHISA ANDO, TAKAYOSHI KISHINO, KENSUKE KUMAMOTO, KIYOTOSHI SATO, MASAHIRO SUGIMOTO, MINA NAGAO, NOBUYUKI MIYATAKE, TAKASHI NORIKANE, TOMOYOSHI SOGA and KEIICHI OKANO

Anticancer Research August 2024, 44 (8) 3321-3330; DOI: https://doi.org/10.21873/anticanres.17151
You have access
A Comparative Analysis of ARX and ANFIS Models for Tumor Growth Prediction Under Single and Multi-agent Chemotherapy
SOTIRIOS G. LILIOPOULOS, GEORGE S. STAVRAKAKIS and KONSTANTINOS S. DIMAS

Anticancer Research June 2024, 44 (6) 2425-2436; DOI: https://doi.org/10.21873/anticanres.17049
Open Access
The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
SKAISTE TULYTE, DAINIUS CHARACIEJUS, REDA MATUZEVICIENE, AUSRA JANIULIONIENE, MANTAS RADZEVICIUS, TADAS ZVIRBLIS and AUDRIUS SILEIKIS

Anticancer Research June 2022, 42 (6) 3067-3073; DOI: https://doi.org/10.21873/anticanres.15794
You have access
FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines
SEBASTIAN K.S. BEGG, DAVID J. BIRNBAUM, JEFFREY W. CLARK, MARI MINO-KENUDSON, ULRICH F. WELLNER, OLIVER SCHILLING, KEITH D. LILLEMOE, ANDREW L. WARSHAW, CARLOS FERNÁNDEZ-DEL CASTILLO and ANDREW S. LISS

Anticancer Research July 2020, 40 (7) 3659-3667; DOI: https://doi.org/10.21873/anticanres.14355
You have access
High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer
KAZUNOBU SUZUKI, AKIRA WATANABE, KENICHIRO ARAKI, TAKEHIKO YOKOBORI, NORIHUMI HARIMOTO, DORGORMAA GANTUMUR, KEI HAGIWARA, TAKAHIRO YAMANAKA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, TAKAMICHI IGARASHI, NORIO KUBO, NAVCHAA GOMBODORJ, MASAHIKO NISHIYAMA, YASUO HOSOUCHI, HIROYUKI KUWANO and KEN SHIRABE

Anticancer Research February 2018, 38 (2) 939-944;
You have access
Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma
SHANE A. GRACE, MARSHALL W. MEEKS, YONGXIN CHEN, MONA CORNWELL, XIANZHONG DING, PING HOU, JOANNE K. RUTGERS, SUSAN E. CRAWFORD and JIN-PING LAI

Anticancer Research February 2017, 37 (2) 699-703;

Main menu

User menu

Search

PDAC